FCN-338

· Fochon Pharmaceuticals, Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for FCN-338, covering 2024-08-13 to 2025-03-05. Get the full timeline:

Most recent: Clinical Trial Update: FCN-338 in Combination With Azacitidine or Chemotherapy in Myeloid Neoplasms [Phase 2]